Growth Opportunity Touch Bionics has recently reported a turnover increase of 23.6% to £18.3m in 2025, indicating rising demand for upper limb prosthetics. This suggests a favorable market trajectory and potential upsell opportunities for advanced myoelectric and finger prosthetic solutions, as well as expanded clinical services.

Strategic Acquisition As part of Össur since 2016, Touch Bionics operates under a larger global spine of orthotics and prosthetics leadership, which may open cross-sell prospects to Össur’s customer base and leverage existing distribution channels for new products and services.

Clinical Services The emphasis on training and a full range of clinical services positions the company as a customer-centric partner. There is an opportunity to introduce remote monitoring, aftercare programs, and consumables bundles to improve patient outcomes and drive recurring revenue.

Product Portfolio With both myoelectric hands and passive silicone prostheses that closely match appearance, there is room to promote integrated solutions combining advanced functional devices with cosmetic options, as well as customization and fitting services to expand share among surgeons and rehabilitation centers.

Market Positioning Operating in a niche with other specialized players and mid-market scale, Touch Bionics can be approached for targeted B2B partnerships with clinics, hospitals, and military or pensioned programs, deploying pilot programs to demonstrate ROI and clinical impact.